More intriguingly, upon TGF-β signaling inhibition in breast cancer model, although the numbers of myCAFs and vCAFs decrease, a new subpopulation of CAFs, interferon-licensed CAFs (ilCAFs), appears [107]. Here, TGFB1 is linked to breast carcinoma.